Kirsten Richter

Their Laboratory Head Kirsten joined Anaveon in June 2021, from Roche pRED where she led preclinical drug discovery projects using locked nucleic acids, small or large molecules to modulate the immune response in the fields of antibiotics, virology, and autoimmunity. Before that, Kirsten was Oberassistentin/senior scientist at the Swiss Federal Institute of Technology (ETH) in Zurich focusing on the immune response in chronic viral infection. She obtained her PhD in Freiburg, Germany. Kirsten has broad immunology expertise and especially likes T cells.